Tacke F - Search Results

1

Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.

Greif S, Maasberg S, Wehkamp J, Fusco S, Zopf Y, Herrmann HJ, Lamprecht G, Jacob T, Schiefke I, von Websky MW, Büttner J, Blüthner E, Tacke F, Pape UF. Greif S, et al. Among authors: tacke f. Clin Nutr ESPEN. 2022 Oct;51:222-230. doi: 10.1016/j.clnesp.2022.08.027. Epub 2022 Aug 28. Clin Nutr ESPEN. 2022. PMID: 36184208

2

Assessing Non-Invasive Liver Function in Patients with Intestinal Failure Receiving Total Parenteral Nutrition-Results from the Prospective PNLiver Trial.

Blüthner E, Pape UF, Stockmann M, Karber M, Maasberg S, Pevny S, Gerlach-Runge U, Pascher A, Pratschke J, Tacke F, Bednarsch J. Blüthner E, et al. Among authors: tacke f. Nutrients. 2020 Apr 26;12(5):1217. doi: 10.3390/nu12051217. Nutrients. 2020. PMID: 32357501 Free PMC article.

3

De Novo Development of Distal Jejunal and Duodenal Adenomas After 41 Months of Teduglutide Treatment in a Patient With Short-Bowel Syndrome: A Case Report.

Pevny S, Pape UF, Elezkurtaj S, Rieger A, Jürgensen C, Blüthner E, Jochum C, Tacke F, Maasberg S. Pevny S, et al. Among authors: tacke f. JPEN J Parenter Enteral Nutr. 2021 Mar;45(3):652-656. doi: 10.1002/jpen.1982. Epub 2020 Aug 21. JPEN J Parenter Enteral Nutr. 2021. PMID: 32740933

4

The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation.

Czigany Z, Kramp W, Lurje I, Miller H, Bednarsch J, Lang SA, Ulmer TF, Bruners P, Strnad P, Trautwein C, von Websky MW, Tacke F, Neumann UP, Lurje G. Czigany Z, et al. Among authors: tacke f. J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):358-367. doi: 10.1002/jcsm.12669. Epub 2021 Feb 1. J Cachexia Sarcopenia Muscle. 2021. PMID: 33525056 Free PMC article.

5

Severe acute respiratory syndrome coronavirus 2 antibody prevalence in adult patients with short bowel syndrome-A German multicenter cross-sectional study.

Blüthner E, Pape UF, Blumenstein I, Wichmann J, Tacke F, Moosburner S. Blüthner E, et al. Among authors: tacke f. JPEN J Parenter Enteral Nutr. 2022 Aug;46(6):1404-1411. doi: 10.1002/jpen.2410. Epub 2022 Jun 27. JPEN J Parenter Enteral Nutr. 2022. PMID: 35616296 Free PMC article.

6

Quality of Life in Teduglutide-Treated Patients with Short Bowel Syndrome Intestinal Failure-A Nested Matched Pair Real-World Study.

Blüthner E, Pape UF, Tacke F, Greif S. Blüthner E, et al. Among authors: tacke f. Nutrients. 2023 Apr 18;15(8):1949. doi: 10.3390/nu15081949. Nutrients. 2023. PMID: 37111167 Free PMC article.

7

[Use of specific antidotes in DOAC-associated severe gastrointestinal bleeding - an expert consensus - Antagonozation of direct oral anticoagulants in gastrointestinal hemorrhages].

Fuhrmann V, Koscielny J, Vasilakis T, Andus T, Herber A, Fusco S, Roeb E, Schiefke I, Rosendahl J, Dollinger M, Caca K, Tacke F. Fuhrmann V, et al. Among authors: tacke f. Z Gastroenterol. 2024 May;62(5):759-768. doi: 10.1055/a-2112-1834. Epub 2023 Aug 16. Z Gastroenterol. 2024. PMID: 37586394 Review. German.

8

Predictive Potential of Biomarkers of Intestinal Barrier Function for Therapeutic Management with Teduglutide in Patients with Short Bowel Syndrome.

Büttner J, Blüthner E, Greif S, Kühl A, Elezkurtaj S, Ulrich J, Maasberg S, Jochum C, Tacke F, Pape UF. Büttner J, et al. Among authors: tacke f. Nutrients. 2023 Sep 29;15(19):4220. doi: 10.3390/nu15194220. Nutrients. 2023. PMID: 37836505 Free PMC article.

9

Real-World Clinical Management of Patients with Primary Biliary Cholangitis-A Retrospective Multicenter Study from Germany.

Wilde AB, Lieb C, Leicht E, Greverath LM, Steinhagen LM, Wald de Chamorro N, Petersen J, Hofmann WP, Hinrichsen H, Heyne R, Berg T, Naumann U, Schwenzer J, Vermehren J, Geier A, Tacke F, Müller T. Wilde AB, et al. Among authors: tacke f. J Clin Med. 2021 Mar 4;10(5):1061. doi: 10.3390/jcm10051061. J Clin Med. 2021. PMID: 33806503 Free PMC article.

10

Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Wilde AB, Greverath LM, Steinhagen LM, de Chamorro NW, Leicht E, Fischer J, Herta T, Berg T, Preuss B, Klein R, Tacke F, Müller T. Wilde AB, et al. Among authors: tacke f. J Clin Med. 2022 Jan 28;11(3):681. doi: 10.3390/jcm11030681. J Clin Med. 2022. PMID: 35160133 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

756 results

Search Page